Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells

Michael S Kuhns, Victoria Epshteyn, Raymond A. Sobel, James P. Allison

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

We examined how cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates heterogeneous CD4+ T cell responses by using experimental autoimmune encephalomyelitis (EAE), a CD4+ T cell-mediated disease that is subject to regulation by CTLA-4. Disease incidence and severity were used as measures of in vivo CD4+ T cell responses. The frequency, cytokine production, and reactivity of primed T cells were determined from animals immunized with proteolipid protein (PLP)-139-151 (disease agonist), PLP-Q (disease antagonist), or both peptides, and treated with control or anti-CTLA-4 antibody to analyze the responding population. CTLA-4 blockade exacerbated disease in PLP-139-151-primed animals and overcame disease antagonism in coimmunized animals, but did not permit disease induction in PLP-Q-primed animals. Experimental autoimmune encephalomyelitis enhancement was associated with increased frequencies of cytokine-producing cells and increased ratios of IFN-γ to IL-4 secretors responsive to PLP-139-151. Priming with PLP-Q elicited IL-4 and IL-2, but not IFN-γ secretors cross-reactive with PLP-139-151. Strikingly, CTLA-4 blockade was found to decrease rather than increase the frequencies of cross-reactive IL-4 and IL-2 secretors. Thus, CTLA-4 engagement limits the size, but increases the breadth, of reactivity of a primed pool of CD4+ T cells, consequently regulating its function.

Original languageEnglish (US)
Pages (from-to)12711-12716
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number23
DOIs
StatePublished - Nov 7 2000
Externally publishedYes

Fingerprint

CTLA-4 Antigen
Proteolipids
T-Lymphocytes
Interleukin-4
Autoimmune Experimental Encephalomyelitis
Interleukin-2
Cytokines
Animal Diseases
Proteins
Peptides
myelin proteolipid protein (139-151)
Antibodies
Incidence
Population

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. / Kuhns, Michael S; Epshteyn, Victoria; Sobel, Raymond A.; Allison, James P.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 23, 07.11.2000, p. 12711-12716.

Research output: Contribution to journalArticle

@article{a0b6ba4cb7ba45808bc2cbf17a8c02a2,
title = "Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells",
abstract = "We examined how cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates heterogeneous CD4+ T cell responses by using experimental autoimmune encephalomyelitis (EAE), a CD4+ T cell-mediated disease that is subject to regulation by CTLA-4. Disease incidence and severity were used as measures of in vivo CD4+ T cell responses. The frequency, cytokine production, and reactivity of primed T cells were determined from animals immunized with proteolipid protein (PLP)-139-151 (disease agonist), PLP-Q (disease antagonist), or both peptides, and treated with control or anti-CTLA-4 antibody to analyze the responding population. CTLA-4 blockade exacerbated disease in PLP-139-151-primed animals and overcame disease antagonism in coimmunized animals, but did not permit disease induction in PLP-Q-primed animals. Experimental autoimmune encephalomyelitis enhancement was associated with increased frequencies of cytokine-producing cells and increased ratios of IFN-γ to IL-4 secretors responsive to PLP-139-151. Priming with PLP-Q elicited IL-4 and IL-2, but not IFN-γ secretors cross-reactive with PLP-139-151. Strikingly, CTLA-4 blockade was found to decrease rather than increase the frequencies of cross-reactive IL-4 and IL-2 secretors. Thus, CTLA-4 engagement limits the size, but increases the breadth, of reactivity of a primed pool of CD4+ T cells, consequently regulating its function.",
author = "Kuhns, {Michael S} and Victoria Epshteyn and Sobel, {Raymond A.} and Allison, {James P.}",
year = "2000",
month = "11",
day = "7",
doi = "10.1073/pnas.220423597",
language = "English (US)",
volume = "97",
pages = "12711--12716",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "23",

}

TY - JOUR

T1 - Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells

AU - Kuhns, Michael S

AU - Epshteyn, Victoria

AU - Sobel, Raymond A.

AU - Allison, James P.

PY - 2000/11/7

Y1 - 2000/11/7

N2 - We examined how cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates heterogeneous CD4+ T cell responses by using experimental autoimmune encephalomyelitis (EAE), a CD4+ T cell-mediated disease that is subject to regulation by CTLA-4. Disease incidence and severity were used as measures of in vivo CD4+ T cell responses. The frequency, cytokine production, and reactivity of primed T cells were determined from animals immunized with proteolipid protein (PLP)-139-151 (disease agonist), PLP-Q (disease antagonist), or both peptides, and treated with control or anti-CTLA-4 antibody to analyze the responding population. CTLA-4 blockade exacerbated disease in PLP-139-151-primed animals and overcame disease antagonism in coimmunized animals, but did not permit disease induction in PLP-Q-primed animals. Experimental autoimmune encephalomyelitis enhancement was associated with increased frequencies of cytokine-producing cells and increased ratios of IFN-γ to IL-4 secretors responsive to PLP-139-151. Priming with PLP-Q elicited IL-4 and IL-2, but not IFN-γ secretors cross-reactive with PLP-139-151. Strikingly, CTLA-4 blockade was found to decrease rather than increase the frequencies of cross-reactive IL-4 and IL-2 secretors. Thus, CTLA-4 engagement limits the size, but increases the breadth, of reactivity of a primed pool of CD4+ T cells, consequently regulating its function.

AB - We examined how cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates heterogeneous CD4+ T cell responses by using experimental autoimmune encephalomyelitis (EAE), a CD4+ T cell-mediated disease that is subject to regulation by CTLA-4. Disease incidence and severity were used as measures of in vivo CD4+ T cell responses. The frequency, cytokine production, and reactivity of primed T cells were determined from animals immunized with proteolipid protein (PLP)-139-151 (disease agonist), PLP-Q (disease antagonist), or both peptides, and treated with control or anti-CTLA-4 antibody to analyze the responding population. CTLA-4 blockade exacerbated disease in PLP-139-151-primed animals and overcame disease antagonism in coimmunized animals, but did not permit disease induction in PLP-Q-primed animals. Experimental autoimmune encephalomyelitis enhancement was associated with increased frequencies of cytokine-producing cells and increased ratios of IFN-γ to IL-4 secretors responsive to PLP-139-151. Priming with PLP-Q elicited IL-4 and IL-2, but not IFN-γ secretors cross-reactive with PLP-139-151. Strikingly, CTLA-4 blockade was found to decrease rather than increase the frequencies of cross-reactive IL-4 and IL-2 secretors. Thus, CTLA-4 engagement limits the size, but increases the breadth, of reactivity of a primed pool of CD4+ T cells, consequently regulating its function.

UR - http://www.scopus.com/inward/record.url?scp=0033731186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033731186&partnerID=8YFLogxK

U2 - 10.1073/pnas.220423597

DO - 10.1073/pnas.220423597

M3 - Article

C2 - 11050166

AN - SCOPUS:0033731186

VL - 97

SP - 12711

EP - 12716

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23

ER -